Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 3.81 B

Boston Scientific Corporation Operating Cash Flow is USD 3.81 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 53.90% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 2.48 B, a 39.63% change year over year.
  • Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.77 B, a 16.10% change year over year.
  • Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.53 B, a -18.25% change year over year.
  • Boston Scientific Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 1.87 B, a 32.65% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities